P3 Health Partners Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
P3 Health Partners's earnings have been declining at an average annual rate of -22.1%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 29.6% per year.
Anahtar bilgiler
-22.1%
Kazanç büyüme oranı
-16.1%
EPS büyüme oranı
| Healthcare Sektör Büyümesi | 8.5% |
| Gelir büyüme oranı | 29.6% |
| Özkaynak getirisi | -50.6% |
| Net Marj | -5.0% |
| Sonraki Kazanç Güncellemesi | 12 Nov 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Health Check: How Prudently Does P3 Health Partners (NASDAQ:PIII) Use Debt?
Aug 26
P3 Health Partners: Moving In The Right Direction In 2024
Jun 07P3 Health Partners GAAP EPS of -$3.73, revenue of $269.45M
Oct 20P3 Health gets Nasdaq notice for delisting, plans appeal
Oct 05P3 Health expands Nevada footprint with acquisition of Pahrump cardiology practice
Aug 29P3 Health Partners receives Nasdaq notice for non-compliance
Aug 19Gelir ve Gider Dağılımı
P3 Health Partners nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 1,403 | -69 | 114 | 0 |
| 31 Mar 24 | 1,353 | -67 | 115 | 0 |
| 31 Dec 23 | 1,266 | -58 | 126 | 0 |
| 30 Sep 23 | 1,178 | -126 | 142 | 0 |
| 30 Jun 23 | 1,138 | -124 | 147 | 0 |
| 31 Mar 23 | 1,078 | -269 | 162 | 0 |
| 31 Dec 22 | 1,049 | -270 | 162 | 0 |
| 30 Sep 22 | 977 | -100 | 185 | 0 |
| 30 Jun 22 | 884 | -121 | 167 | 0 |
| 31 Mar 22 | 760 | 4 | 144 | 0 |
| 31 Dec 21 | 637 | -10 | 119 | 0 |
| 30 Sep 21 | 582 | -90 | 72 | 0 |
| 30 Jun 21 | 555 | -74 | 66 | 0 |
| 31 Mar 21 | 527 | -49 | 59 | 0 |
| 31 Dec 20 | 491 | -31 | 55 | 0 |
| 31 Dec 19 | 145 | -42 | 37 | 0 |
Kaliteli Kazançlar: PIII is currently unprofitable.
Büyüyen Kar Marjı: PIII is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: PIII is unprofitable, and losses have increased over the past 5 years at a rate of 22.1% per year.
Büyüme Hızlandırma: Unable to compare PIII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: PIII is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Özkaynak Getirisi
Yüksek ROE: PIII has a negative Return on Equity (-50.65%), as it is currently unprofitable.